Company Monitoring Page for Aegerion

latest headlines for company on cafepharma

Have These 4 Biotechs Peaked?
Motley Fool
Mon, 09/16/13 - 11:04 am
Tags:
biotech, Alexion, Pharmacyclics, Aegerion, Raptor Pharmaceuticals
Why Aegerion Is Worth 1,732 Times Sales
Seeking Alpha
Wed, 06/12/13 - 08:50 am
Tags:
Aegerion, Juxtapid
Aegerion Continues To Gain Momentum As Analysts Raise Price Targets
Seeking Alpha
Thu, 05/30/13 - 04:49 pm
Tags:
Aegerion, Juxtapid
Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?
Wall Street Cheat Street
Sat, 04/27/13 - 10:10 am
Tags:
Aegerion, earnings
2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Wed, 04/24/13 - 04:46 pm
Tags:
orphan drugs, Raptor Pharmaceuticals, Aegerion, Juxtapid, procysbi
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Tags:
Arena Pharmaceuticals, Zogenix, Delcath, Aveo Pharmaceutical, Vivus, Titan Pharmaceuticals, Bristol-Myers Squibb, Merck, Gilead, AbbVie, Amarin, Achillion, Sangamo BioSciences, Raptor Pharmaceuticals, Vertex Pharmaceuticals, NewLink Genetics, AstraZeneca, Rigel, Depomed, Biogen Idec, Sucampo, Dendreon, Valeant Pharmaceuticals, GSK, Aegerion
Aegerion stock continues to climb after full-year financials
Bizjournals.com
Thu, 03/7/13 - 11:35 am
Tags:
Aegerion, earnings
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 03/4/13 - 10:46 am
Tags:
Depomed, FDA, Serada, Breo Ellipta, COPD, GSK, Theravance, Aegerion, Sarepta
Aegerion Pharmaceuticals Expected To Take A Hit
Seeking Alpha
Sat, 02/2/13 - 12:05 pm
Tags:
Aegerion
Better Cancer Treatment: Partnerships and Dividends
The Motley Fool
Sat, 01/19/13 - 12:12 pm
Tags:
cancer, treatment, Isis Pharmaceuticals, Aegerion, Astra Zeneca
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Tags:
Eisai, Sarepta, Arena Pharmaceuticals, Amarin, Gilead, Biomarin, Onyx, Medivation, Achillion, Incyte, Cell Therapeutics, Celgene, NPS Pharmaceuticals, Aegerion, Roche, Biogen Idec, Ariad Pharmaceuticals, Alexza, Navidea, Aveo
Better Than Lipitor! Higher Sales?
Motley Fool
Tue, 01/1/13 - 11:53 am
Tags:
Pfizer, Lipitor, Juxtapid, Aegerion, Kynamro, Sanofi, Isis Pharmaceuticals, Regeneron, Alnylam, PCSK9 inhibitors
Why Aegerion Keeps Winning
Motley Fool
Sat, 12/29/12 - 09:59 am
Tags:
Aegerion
Several Reasons Why I'm Considering These 2 Biotech Firms Before Year's End
Seeking Alpha
Wed, 12/26/12 - 09:21 pm
Tags:
Raptor Pharmaceuticals, Aegerion
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Yahoo/AP
Mon, 12/24/12 - 10:30 am
Tags:
lomitapide, Homozygous Familial Hypercholesterolemia, Juxtapid, Aegerion, FDA
Aegerion Hits New High
Motley Fool
Sat, 12/15/12 - 12:54 pm
Tags:
Aegerion, lomitapide, Homozygous Familial Hypercholesterolemia, cholesterol
New drug holds promise as therapy for rare and deadly cholesterol disorder
Equities.com
Sun, 11/4/12 - 10:43 am
Tags:
lomitapide, hypercholesterolemia, Aegerion
Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipated
Seeking Alpha
Wed, 10/24/12 - 10:58 am
Tags:
lomitapide, FDA, Aegerion, Homozygous Familial Hypercholesterolemia
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Tags:
Aegerion, Isis Pharmaceuticals, Sanofi, NPS Pharmaceuticals, Aeterna Zentaris
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 10/20/12 - 10:43 am
Tags:
Siemens, Aegerion, Given Imaging

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.